E. Driscoll

发表

Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue‐type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist

B. R. Lucchessi, W. Rote, E. Driscoll, 1994, British journal of pharmacology.

The Antithrombotic Effect of Melagatran in Combination With Clopidogrel and/or Aspirin (carotid artery primary thrombosis study)

B. Lucchesi, Jinbao Huang, E. Driscoll, 2005, Journal of cardiovascular pharmacology.

Disodium Disuccinate Astaxanthin Prevents Carotid Artery Rethrombosis and ex vivo Platelet Activation

B. Lucchesi, E. Driscoll, D. Lauver, 2008, Pharmacology.

Superoxide Dismutase Conjugated to Polyethylene Glycol Provides Sustained Protection Against Myocardial Ischemia/ Reperfusion Injury in Canine Heart

K. Gallagher, B. Freeman, L. Chi, 1988, Circulation research.

The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase.

B. Pitt, S. Werns, B. Lucchesi, 1985, Circulation research.

Reduction by Superoxide Dismutase but not Catalase

B. Pitt, S. Werns, B. Lucchesi, 2005 .

Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.

B. Lucchesi, A. Cardin, J. Hennan, 2002, The Journal of pharmacology and experimental therapeutics.

Microvascular permeabilization and cardiomyocyte injury provoked by myocardial contrast echocardiography in a canine model.

Douglas L. Miller, B. Lucchesi, Chunyan Dou, 2006, Journal of the American College of Cardiology.

Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries

L. Crofford, B. Lucchesi, T. Barrett, 2001, Circulation.

TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog.

B. Lucchesi, S. Rebello, E. Driscoll, 1997, Stroke.

Preclinical Evaluation of S18886 in an Experimental Model of Coronary Arterial Thrombosis

B. Lucchesi, Jinbao Huang, E. Driscoll, 2006, Journal of cardiovascular pharmacology.

Effects of the Positive Inotropic Agents Milrinone and Pimobendan on the Development of Lethal Ischemic Arrhythmias in Conscious Dogs with Recent Myocardial Infarction

A. Uprichard, B. Lucchesi, J. Lynch, 1989, Journal of cardiovascular pharmacology.

Platelet‐Activating Factor and the Release of a Platelet‐Derived Coronary Artery Vasodilator Substance in the Canine

S. Kunkel, B. Lucchesi, W. Schumacher, 1986, Circulation research.

BMY21190, A Potent Inhibitor of cAMP Phosphodiesterase

M. Minami, M. Hirafuji, B. Lucchesi, 1994 .

Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.

J. Borlak, B. Lucchesi, J. Borlak, 1998, Journal of cardiovascular pharmacology.

Tedisamil and dofetilide‐induced torsades de pointes, rate and potassium dependence

B. Lucchesi, T. Barrett, J. Hennan, 2001, British journal of pharmacology.

Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury.

B. Lucchesi, G. Friedrichs, K. Kilgore, 1995, Cardiovascular research.

Antiarrhythmic and Electrophysiologic Actions of CK‐357 and Sematilide in a Conscious Canine Model of Sudden Coronary Death

L. Chi, B. Lucchesi, E. Driscoll, 1990, Journal of cardiovascular pharmacology.

Effect of ranolazine on infarct size in a canine model of regional myocardial ischemia/reperfusion.

J. Mccormack, B. Lucchesi, M. Gralinski, 1994, Journal of cardiovascular pharmacology.

Glycoprotein IIb/IIIa Receptor Antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-{[2-({4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl}amino)acetyl]amino}propanoic Acid Dihydrochloride (CRL42796), in Combination with Aspirin and/or Enoxaparin, Prevents Coronary Artery Rethrombosis after Success

A. J. White, Andrew J. White, B. Lucchesi, 2003, Journal of Pharmacology and Experimental Therapeutics.

butanoyl } amino ) acetyl ] amino } propanoic Acid Dihydrochloride ( CRL 42796 ) , in Combination with Aspirin and / or Enoxaparin , Prevents Coronary Artery Rethrombosis after Successful Thrombolytic Treatment by Recombinant Tissue Plasminogen Activator

Andrew J. White, B. Lucchesi, E. Driscoll, 2003 .

Prevention of Carotid Artery Thrombosis After Oral Administration of the Glycoprotein IIb/IIIa Antagonist CRL42796

B. Lucchesi, J. Hennan, E. Driscoll, 2003, Journal of cardiovascular pharmacology.

Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796

B. Lucchesi, J. Hennan, E. Driscoll, 2002, British journal of pharmacology.

The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.

B. Pitt, B. Lucchesi, J. Romson, 1984, American heart journal.

Alinidine Reduces the Incidence of Ischemic Ventricular Fibrillation in a Conscious Canine Model, a Protective Effect Antagonized by Overdrive Atrial Pacing

L. Chi, A. Uprichard, B. Lucchesi, 1989, Journal of cardiovascular pharmacology.

Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.

Michael L. Gonzales, B. Lucchesi, M. L. Gonzales, 2000, The Journal of pharmacology and experimental therapeutics.

Inhibition of in vivo myocardial ischemic and reperfusion injury by a synthetic manganese-based superoxide dismutase mimetic.

B. Lucchesi, D. Riley, C. Schasteen, 1994, The Journal of pharmacology and experimental therapeutics.

Inhibition of coronary artery reocclusion after thrombolysis with an RGD‐containing peptide with no significant effect on bleeding time

B. Lucchesi, M. Pierschbacher, E. Driscoll, 1993, Coronary artery disease.

Thrombostatin Inhibits Cyclic Flow Variations in Stenosed Canine Coronary Arteries

A. Schmaier, D. Normolle, S. Werns, 2001, Thrombosis and Haemostasis.

Thrombostatin Inhibits Induced Canine Coronary Thrombosis

D. Normolle, S. Werns, B. Lucchesi, 1999, Thrombosis and Haemostasis.

Reduction of Myocardial Necrosis after Glycosaminoglycan Administration: Effects of a Single Intravenous Administration of Heparin or N-Acetylheparin 2 Hours before Regional Ischemia and Reperfusion

B. Lucchesi, G. Friedrichs, M. Gralinski, 1996 .

Effect of Sodium/Hydrogen Exchange Inhibition on Myocardial Infarct Size after Coronary Artery Thrombosis and Thrombolysis

B. Lucchesi, T. Barrett, J. Hennan, 2006, Pharmacology.

Effect of Ramiprilat or Captopril on Myocardial Infarct Size: Assessment in Canine Models of Ischemia Alone and Ischemia with Reperfusion

B. Lucchesi, E. Driscoll, S. Black, 1998, Pharmacology.

Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog.

B. Pitt, B. Lucchesi, J. Romson, 1984, European journal of pharmacology.

Inhibition of Platelet-Activating Factor Fails to Limit Ischemia and Reperfusion-Induced Myocardial Damage

B. Lucchesi, E. Driscoll, S. Black, 1992, Journal of cardiovascular pharmacology.

The effect of diltiazem on coronary thrombosis in the conscious canine.

B. Lucchesi, L. Bush, J. Romson, 1982, European journal of pharmacology.

Antithrombotic effects of BMY21190, an inhibitor of cAMP phosphodiesterase, in a canine model of coronary artery thrombosis.

M. Minami, B. Lucchesi, E. Driscoll, 1993, Japanese circulation journal.

Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine.

B. Lucchesi, S. Nelson, J. Lynch, 1987, The Journal of pharmacology and experimental therapeutics.